R Inagi
Overview
Explore the profile of R Inagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
846
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Miyata T, Sugiyama S, Suzuki D, Inagi R, Kurokawa K
Kidney Int Suppl
. 1999 Jul;
71:S54-6.
PMID: 10412738
Background: In diabetic nephropathy (DN), possible mediators of untoward effects of hyperglycemia include the advanced glycation end products (AGEs). Indeed, an AGE, carboxymethyllysine (CML), accumulates in expanded mesangial matrix and...
22.
Miyata T, Sugiyama S, Nangaku M, Suzuki D, Uragami K, Inagi R, et al.
J Am Soc Nephrol
. 1999 Jul;
10(7):1590-5.
PMID: 10405216
Lipid abnormalities are associated with various disorders ranging from generalized atherosclerosis to renal diseases, including lipoprotein glomerulopathy that is characterized by glomerular lipoprotein thrombi and causes type III hyperlipoproteinemia, proteinuria,...
23.
Kositanont U, Wasi C, Wanprapar N, Bowonkiratikachorn P, Chokephaibulkit K, Chearskul S, et al.
J Infect Dis
. 1999 Jun;
180(1):50-5.
PMID: 10353860
The role of human herpesvirus 6 (HHV-6) infection in 227 children born to human immunodeficiency virus (HIV)-seropositive mothers was investigated. Of 41 HIV-uninfected infants, 3 (7%) were positive for HHV-6...
24.
Matsumoto K, Kato A, Inagi R, Yamanishi K, Kawano K
Acta Neurochir (Wien)
. 1999 Jun;
141(4):439-40.
PMID: 10352757
No abstract available.
25.
Inagi R, Okuno T, Ito M, Chen J, Mori Y, Haque M, et al.
J Hum Virol
. 1999 May;
2(2):63-71.
PMID: 10225208
Objective: To identify and characterize an open reading frame (ORF) in association with its mRNA and a coding protein recognized by anti-human herpesvirus 8 (HHV-8) monoclonal antibody B291. Study Design/methods:...
26.
Miyata T, Inagi R, Kurokawa K
Miner Electrolyte Metab
. 1999 Apr;
25(1-2):114-7.
PMID: 10207272
Dialysis-related amyloidosis (DRA) is a major complication of chronic renal failure and long-term renal replacement therapy. Beta2-Microglobulin is a major constituent of amyloid fibrils in DRA. Amyloid deposition mainly involves...
27.
Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, et al.
J Am Soc Nephrol
. 1999 Apr;
10(4):822-32.
PMID: 10203367
Advanced glycation end products (AGE) include a variety of protein adducts whose accumulation has been implicated in tissue damage associated with diabetic nephropathy (DN). It was recently demonstrated that among...
28.
Izuhara Y, Miyata T, Ueda Y, Suzuki D, Asahi K, Inagi R, et al.
Nephrol Dial Transplant
. 1999 Apr;
14(3):576-80.
PMID: 10193802
Background: Advanced glycation end products are formed by non-enzymatic glycation and oxidation reaction. Pentosidine is a well-known and characterized structure among them, and has been implicated in the pathogenesis of...
29.
Miyata T, Ishikawa S, Asahi K, Inagi R, Suzuki D, Horie K, et al.
FEBS Lett
. 1999 Mar;
445(1):202-6.
PMID: 10069401
We have pursued the hypothesis that the carbonyl modification of proteins by glycoxidation and lipoxidation reactions plays a role in atherogenesis. Human atherosclerotic tissues with fatty streaks and uremic arteriosclerotic...
30.
Sugiyama S, Miyata T, Inagi R, Kurokawa K
Int J Mol Med
. 1998 Dec;
2(5):561-5.
PMID: 9858652
Dialysis-related amyloidosis is recognized as a serious bone and joint complication in long-term dialysis patients. Beta2-microglobulin has been demonstrated to be a major constituent of the amyloid fibrils. However, the...